mouse model Archives | Be Korea-savvy

Home / Posts tagged mouse model

Taconic Biosciences Launches First and Only Super Immunodeficient Mouse Models Lacking Residual Murine Fc Gamma Receptors, for Improved Antibody Therapy Assessment

RENSSELAER, N.Y., Oct. 24 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, has launched the FcResolv™ NOG portfolio, the first and only super immunodeficient mouse models lacking residual murine Fc gamma receptors (FcγRs) known to confound results in antibody-based therapy studies. Murine FcγRs can cause false positives or [...]

Taconic Biosciences Launches New COVID-19 Mouse Model

RENSSELAER, N.Y., April 29 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of a new COVID-19 mouse model. This human ACE2 (hACE2) transgenic mouse expands Taconic’s COVID-19 research toolkit. In October 2020, Taconic launched its first hACE2 model. The AC70 mouse experiences a lethal response to [...]

Taconic Biosciences Launches Critical Model for COVID-19 Research

RENSSELAER, N.Y., Oct. 26 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces immediate humanized ACE2 mouse model availability for COVID-19 research. The SARS-CoV-2 virus, which causes COVID-19, uses the ACE2 receptor to enter cells. Due to differences between the mouse and human ACE2 receptors, normal laboratory mice [...]

Taconic Biosciences Expands Production of Critical Immunodeficient Model

RENSSELAER, N.Y., June 10 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces local West Coast United States production of the immunodeficient CIEA NOG mouse® model. Immunodeficient animal models are critical to the drug discovery ecosystem. One of the most common contributors to the high product attrition rate for [...]

Taconic Biosciences Launches New Immuno-oncology Mouse Model

RENSSELAER, N.Y., Jan. 31 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its premier immuno-oncology portfolio with the launch of the new B2m-NOG mouse model. Immuno-oncology leverages the body’s immune system to fight cancer, increasing the ability to target the disease. Animal models used in this therapeutic development [...]

Taconic Biosciences Launches Alzheimer’s Disease Mouse Model

RENSSELAER, N.Y., Nov. 4 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its robust neurodegeneration portfolio with the launch of a new Alzheimer’s disease model, the ARTE10 mouse model. Exclusively available from Taconic, the ARTE10 is a transgenic mouse model expressing mutant human APP and PS1 genes. This combination manifests [...]

Neuralstem Announces Publication of a Study Showing Benefits of Neural Stem Cell (NSC) Transplantation in a Mouse Model of Alzheimer’s Disease

GERMANTOWN, Md., Oct. 25 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on developing novel treatments for nervous system diseases, announced the publication of a manuscript in Scientific Reports showing that transplantation of NSI-532.IGF1, a proprietary human neural stem cell line developed by Neuralstem (US patent no 9,750,769), mitigates disease pathology and improves [...]

Taconic Biosciences Announces Expansion of Key Alzheimer Animal Model

HUDSON, N.Y., May 3 (Korea Bizwire) — Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it will expand the offering of a key Alzheimer’s Disease (AD) mouse model, APPSWE – Model 1349, to include aged animals. Taconic will now offer off-the-shelf Model 1349 animals aged up to 42 weeks, [...]